Chicago-based biofabrication company Dimension Inx has been granted a U.S. patent covering its 3D-Painting System, a platform built for designing and manufacturing next-gen biomaterials for organ and tissue repair and regeneration.

 .

The company says the patent issuance strengthens its position on the market by showcasing the differentiation of its biomaterials offering . The biofabrication company was born out of biomaterials research pioneered by co-founders Ramille Shah, PhD, and Adam Jakus, PhD, at Northwestern University’s Tissue Engineering and Additive Manufacturing Lab. The pair developed a portfolio of biomaterials over nearly a decade before spinning off with Dimension Inx, which now holds exclusive worldwide rights to commercialize the 3D-Painting System and associated materials.

 .

Dimension Inx’s now patent-protected 3D-Painting System is capable of high loading bioactive ingredients and rapid printing of biomaterials. Notably, the platform is designed to dry at room temperature, effectively eliminating the need for sintering—which can effect bioactivity—and other […]

Click here to view original web page at www.3dprintingmedia.network